We are live on ! Find out more
MBIO icon

Mustang Bio
MBIO

71 hedge funds and large institutions have $10.3M invested in Mustang Bio in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% less ownership

Funds ownership: 0.03% → 0.02% (-0.01%)

12% less funds holding

Funds holding: 81 → 71 (-10)

39% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 23

40% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 25

59% less capital invested

Capital invested by funds: $25.2M → $10.3M (-$14.9M)

Holders
71
Holders Change
-10
Holders Change %
-12.35%
% of All Funds
1.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
15
Reduced
25
Closed
23
Calls
$61K
Puts
–
Net Calls
+$61K
Net Calls Change
+$15K

Top Buyers

Rank Fund Capital Flow
1
LCM
Laurion Capital Management
New York
+$1.07M
2
Millennium Management
Millennium Management
New York
+$463K
3
Citadel Advisors
Citadel Advisors
Florida
+$380K
4
E
Ergoteles
New York
+$249K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$113K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.52M
2
N
Nuveen
North Carolina
-$1.32M
3
State Street
State Street
Massachusetts
-$896K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$589K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$471K
Name Holding Trade Value Shares
Change 		Change in
Stake
Macquarie Group
26
Macquarie Group
Australia
$70K – – –
Fidelity Investments
27
Fidelity Investments
Massachusetts
$65K +$554 +1 +0.7%
Envestnet Asset Management
28
Envestnet Asset Management
Illinois
$51K +$19.4K +35 +43%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$44K -$135K -244 -71%
Barclays
30
Barclays
United Kingdom
$41K -$8.86K -16 -15%
Qube Research & Technologies (QRT)
31
Qube Research & Technologies (QRT)
United Kingdom
$32K +$40.4K +73 New
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
$31.4K +$32.7K +59 +454%
CAN
33
Cetera Advisor Networks
California
$31K +$38.8K +70 New
Ameriprise
34
Ameriprise
Minnesota
$27K -$13.8K -25 -29%
OC
35
Oppenheimer & Co
New York
$26K – – –
DC
36
Davenport & Co
Virginia
$21K -$2.21K -4 -8%
AQR Capital Management
37
AQR Capital Management
Connecticut
$21K +$14.4K +26 +118%
FAIM
38
Financial Advocates Investment Management
Washington
$21K +$14.4K +26 +113%
LP
39
LMR Partners
United Kingdom
$21K +$26K +47 New
Charles Schwab
40
Charles Schwab
California
$19K -$121K -219 -84%
EL
41
EMFO LLC
Florida
$19K – – –
FLPIM
42
F.L. Putnam Investment Management
Massachusetts
$15K – – –
Osaic Holdings
43
Osaic Holdings
Arizona
$15K +$4.43K +8 +31%
BFM
44
Boothbay Fund Management
New York
$13K -$19.4K -35 -55%
UWM
45
Urban Wealth Management
California
$13K +$16.1K +29 New
LWAM
46
Legacy Wealth Asset Management
Minnesota
$12K +$14.9K +27 New
Commonwealth Equity Services
47
Commonwealth Equity Services
Massachusetts
$11K +$14.4K +26 New
Bank of America
48
Bank of America
North Carolina
$10K – – –
SCA
49
Sassicaia Capital Advisers
New York
$10K +$3.32K +6 +38%
Group One Trading
50
Group One Trading
Illinois
$9K -$7.75K -14 -40%
1
2
3 4

MBIO Hedge Fund Activity: Q2 2022 in Review

71 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2022, worth a combined $10.3M — down 59% from $25.2M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of MBIO and 14 opened new positions — a net loss of 9 holders — while 25 trimmed existing stakes and 15 added.

The largest buyer was Laurion Capital Management, opening a new position worth an estimated $1.07M. The largest seller was BlackRock, cutting an estimated $2.52M.

  • 71 institutional investors held Mustang Bio (MBIO) as of Q2 2022, down from 81 in Q1 2022.
  • Funds reported $10.3M of Mustang Bio stock for Q2 2022, down 59% quarter-over-quarter.
  • 14 funds opened new Mustang Bio positions in Q2 2022 and 23 closed out, a net change of -9 holders.
  • The largest Mustang Bio buyer in Q2 2022 was Laurion Capital Management, an estimated $1.07M added.
  • The largest Mustang Bio seller in Q2 2022 was BlackRock, an estimated $2.52M sold.

Based on aggregated 13F filings for Q2 2022.